222 related articles for article (PubMed ID: 28815768)
1. Micro-vesicles derived from human Wharton's Jelly mesenchymal stromal cells mitigate renal ischemia-reperfusion injury in rats after cardiac death renal transplantation.
Wu X; Yan T; Wang Z; Wu X; Cao G; Zhang C; Tian X; Wang J
J Cell Biochem; 2018 Feb; 119(2):1879-1888. PubMed ID: 28815768
[TBL] [Abstract][Full Text] [Related]
2. Microvesicles derived from human Wharton's Jelly mesenchymal stem cells ameliorate ischemia-reperfusion-induced renal fibrosis by releasing from G2/M cell cycle arrest.
Chen W; Yan Y; Song C; Ding Y; Du T
Biochem J; 2017 Dec; 474(24):4207-4218. PubMed ID: 29150436
[TBL] [Abstract][Full Text] [Related]
3. Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1.
Zou X; Zhang G; Cheng Z; Yin D; Du T; Ju G; Miao S; Liu G; Lu M; Zhu Y
Stem Cell Res Ther; 2014 Mar; 5(2):40. PubMed ID: 24646750
[TBL] [Abstract][Full Text] [Related]
4. The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism.
Du T; Cheng J; Zhong L; Zhao XF; Zhu J; Zhu YJ; Liu GH
Cytotherapy; 2012 Nov; 14(10):1215-27. PubMed ID: 22920838
[TBL] [Abstract][Full Text] [Related]
5. The anti-oxidative role of micro-vesicles derived from human Wharton-Jelly mesenchymal stromal cells through NOX2/gp91(phox) suppression in alleviating renal ischemia-reperfusion injury in rats.
Zhang G; Zou X; Miao S; Chen J; Du T; Zhong L; Ju G; Liu G; Zhu Y
PLoS One; 2014; 9(3):e92129. PubMed ID: 24637475
[TBL] [Abstract][Full Text] [Related]
6. Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells.
Du T; Zou X; Cheng J; Wu S; Zhong L; Ju G; Zhu J; Liu G; Zhu Y; Xia S
Stem Cell Res Ther; 2013 Jun; 4(3):59. PubMed ID: 23734757
[TBL] [Abstract][Full Text] [Related]
7. Microvesicles derived from human umbilical cord mesenchyme promote M2 macrophage polarization and ameliorate renal fibrosis following partial nephrectomy via hepatocyte growth factor.
Du T; Ju G; Zhou J; Zhong L; Rong L; Chen W; Zhang X; Zhou R; Ding D; Ji T
Hum Cell; 2021 Jul; 34(4):1103-1113. PubMed ID: 33860459
[TBL] [Abstract][Full Text] [Related]
8. Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.
Cóndor JM; Rodrigues CE; Sousa Moreira Rd; Canale D; Volpini RA; Shimizu MH; Camara NO; Noronha Ide L; Andrade L
Stem Cells Transl Med; 2016 Aug; 5(8):1048-57. PubMed ID: 27280799
[TBL] [Abstract][Full Text] [Related]
9. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury.
Gatti S; Bruno S; Deregibus MC; Sordi A; Cantaluppi V; Tetta C; Camussi G
Nephrol Dial Transplant; 2011 May; 26(5):1474-83. PubMed ID: 21324974
[TBL] [Abstract][Full Text] [Related]
10. Human umbilical cord-derived mesenchymal stromal cells protect against premature renal senescence resulting from oxidative stress in rats with acute kidney injury.
Rodrigues CE; Capcha JM; de Bragança AC; Sanches TR; Gouveia PQ; de Oliveira PA; Malheiros DM; Volpini RA; Santinho MA; Santana BA; Calado RD; Noronha IL; Andrade L
Stem Cell Res Ther; 2017 Jan; 8(1):19. PubMed ID: 28129785
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Progenitor Cells Derived From Wharton's Jelly of Human Umbilical Cord Attenuate Ischemic Acute Kidney Injury by Increasing Vascularization and Decreasing Apoptosis, Inflammation, and Fibrosis.
Liang CJ; Shen WC; Chang FB; Wu VC; Wang SH; Young GH; Tsai JS; Tseng YC; Peng YS; Chen YL
Cell Transplant; 2015; 24(7):1363-77. PubMed ID: 24819279
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-β1 promotes homing of bone marrow mesenchymal stem cells in renal ischemia-reperfusion injury.
Si X; Liu X; Li J; Wu X
Int J Clin Exp Pathol; 2015; 8(10):12368-78. PubMed ID: 26722423
[TBL] [Abstract][Full Text] [Related]
13. Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease.
Wang Y; Lu X; He J; Zhao W
Stem Cell Res Ther; 2015 May; 6(1):100. PubMed ID: 25998259
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells microvesicles stabilize endothelial barrier function partly mediated by hepatocyte growth factor (HGF).
Wang H; Zheng R; Chen Q; Shao J; Yu J; Hu S
Stem Cell Res Ther; 2017 Sep; 8(1):211. PubMed ID: 28969681
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury.
Chen Y; Qian H; Zhu W; Zhang X; Yan Y; Ye S; Peng X; Li W; Xu W
Stem Cells Dev; 2011 Jan; 20(1):103-13. PubMed ID: 20446811
[TBL] [Abstract][Full Text] [Related]
16. The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury.
Ranghino A; Bruno S; Bussolati B; Moggio A; Dimuccio V; Tapparo M; Biancone L; Gontero P; Frea B; Camussi G
Stem Cell Res Ther; 2017 Feb; 8(1):24. PubMed ID: 28173878
[TBL] [Abstract][Full Text] [Related]
17. Renal subcapsular transplantation of hepatocyte growth factor-producing mesothelial cell sheets improves ischemia-reperfusion injury.
Miyabe Y; Sekiya S; Sugiura N; Oka M; Karasawa K; Moriyama T; Nitta K; Shimizu T
Am J Physiol Renal Physiol; 2019 Aug; 317(2):F229-F239. PubMed ID: 31091122
[TBL] [Abstract][Full Text] [Related]
18. Microvesicles derived from human Wharton's Jelly mesenchymal stem cells ameliorate acute lung injury partly mediated by hepatocyte growth factor.
Chen W; Wang S; Xiang H; Liu J; Zhang Y; Zhou S; Du T; Shan L
Int J Biochem Cell Biol; 2019 Jul; 112():114-122. PubMed ID: 31100425
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell-derived microparticles ameliorate peritubular capillary rarefaction via inhibition of endothelial-mesenchymal transition and decrease tubulointerstitial fibrosis in unilateral ureteral obstruction.
Choi HY; Lee HG; Kim BS; Ahn SH; Jung A; Lee M; Lee JE; Kim HJ; Ha SK; Park HC
Stem Cell Res Ther; 2015 Mar; 6(1):18. PubMed ID: 25889661
[TBL] [Abstract][Full Text] [Related]
20. Enhanced therapeutic effects of mesenchymal stem cells on myocardial infarction by ischemic postconditioning through paracrine mechanisms in rats.
Fang J; Chen L; Fan L; Wu L; Chen X; Li W; Lin Y; Wang W
J Mol Cell Cardiol; 2011 Nov; 51(5):839-47. PubMed ID: 21763697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
